Fast Five Quiz: Heart Failure Management

Yasmine S. Ali, MD

Disclosures

September 11, 2019

The goals of pharmacologic therapy for patients with acute and chronic heart failure include preload/afterload reduction, inhibiting neurohormonal activation, and improving LVEF.

Preload and afterload reduction is accomplished through use of diuretics, vasodilators, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), or combination ACEI/ARB therapy. Neurohormonal activation inhibition through the use of ACEI/ARBs, beta-blockers, and aldosterone agonists show long-term survival benefits.

Organ hypoperfusion, lowering risk for neurologic disease, and reducing PVD are not goals of pharmacologic therapy for patients with acute and chronic heart failure.

For more on the goals of pharmacologic therapy for heart failure, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....